Daisuke Katayama is a people-first P&L leader with over 15 years of experience in specialty pharma and biotech, demonstrating success in immunology, neurology, dermatology, and endocrinology. Currently, Daisuke serves as the Director and Head of the Inflammation & Immunology Business Unit at Amgen. Previously, Daisuke held various roles at Eli Lilly Japan K.K., including Brand Leader in Ped Endocrinology and District Sales Manager, as well as a Group Manager for Digital at Novartis. Daisuke earned a Bachelor of Laws (LLB) from Kindai University and has a strong focus on talent development and organizational engagement.
This person is not in the org chart
This person is not in any teams
This person is not in any offices